| abstract |
Embodiments of the invention generally fall into the category of activated thymulin synthesis and applications thereof. Embodiments, delivered orally or parenterally, are used to treat malignancies and immune system dysfunctions by activating cytotoxic T cells, increasing the generation of T helper 1 cells and/or boosting the production of interleukin 2. |